NCT06393881View on ClinicalTrials.gov

A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

September 14, 2024

Study Completion Date

September 21, 2024

Conditions

Gastro-Intestinal Disorder

Interventions

DRUG

UI059

take UI059 once a day for 7 days

DRUG

UIC202201

take UIC202201 once a day for 7 days

Trial Locations (1)

28644

Chungbuk national university hospital, Cheongju-si

All Listed Sponsors

lead

Korea United Pharm. Inc.

INDUSTRY

NCT06393881 - A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201 | Biotech Hunter | Biotech Hunter